Pradaxa Lawsuit Update: 150 Claims Filed in Federal Multidistrict Litigation on Behalf of Alleged Victims of Pradaxa Bleeding Side Effects, Bernstein Liebhard LLP Reports

Share Article

The firm continues to evaluate potential Pradaxa lawsuits on behalf of individuals who suffered life-threatening bleeding, allegedly due to Pradaxa.

Bernstein Liebhard LLP | Consumer Injury Lawyers
In light of how heavily Pradaxa was marketed, we certainly expect a large litigation.

At least 150 Pradaxa lawsuits are now pending in a federal multidistrict litigation currently underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a December 11, 2012 Bloomberg News article, all of the claims allege plaintiffs suffered serious, life-threatening episodes of internal bleeding due to their use of the drug. Plaintiffs further allege Boehringer Ingelheim, the maker of Pradaxa, sold the blood thinner despite knowing it could cause fatal internal bleeding in some patients. Attorneys interviewed by Bloomberg asserted the company could face thousands of similar claims in the coming years. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)*

“In light of how heavily Pradaxa was marketed, we certainly expect a large litigation,” says Bernstein Liebhard LLP, a national law firm representing clients who have been injured by dangerous drugs and defective medical devices. The firm is currently offering free and confidential lawsuit evaluations to victims of Pradaxa bleeding side effects.

Pradaxa Bleeding Side Effects
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. Since coming to market, Pradaxa has generated more than $1 billion in sales for Boehringer, according to Bloomberg.

Unlike warfarin, the blood thinner Pradaxa was intended to replace, there is no readily-available antidote for bleeding caused by Pradaxa. Dialysis can be used to remove Pradaxa from the blood stream. However, a study published in May in the journal, Neurology, found this treatment is risky and may not be administered in enough time to stop Pradaxa bleeding.** According to Bloomberg, the FDA received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011. The Institute of Safe Medication Practices has also reported that Pradaxa has generated more reports of injury or death than any of the 800 drugs it monitors.

Federally-filed Pradaxa lawsuits have been consolidated in a multidistrict litigation before Judge David Herndon in U.S. District Court, Southern District of Illinois. According to court records, the next Status Conference in the Pradaxa litigation is scheduled for December 13, 2012.

Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more about filing a Pradaxa lawsuit, please visit our website, or call 1-877-779-1414 to speak with one of our attorneys today.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website